In addition, it has been demonstrated that the over-activation of JAK2/STAT3 is implicated in AML tumorigenesis, and targeting this pathway enhances the anti-tumor effects of arsenic trioxide in AML cells [23]. The gene discussed is STAT3; the disease is acute myeloid leukemia.